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A B S T R A C T
A 64-year-old male with Budd–Chiari syndrome (BCS) due to inferior vena cava (IVC) occlusion after liver
transplant presented with massive ascites and lower extremity edema. He was found to have chronic
total occlusion of the supra-hepatic IVC with thrombosis in the infra-hepatic IVC, hepatic, renal, and iliac
veins. Attempts to recanalize the occlusion by multiple operators failed. He was not a surgical candidate.
The patient underwent venography of the IVC, and placement of a McNamara catheter for catheter-
directed thrombolysis on the ﬁrst day. The second day, he underwent right internal jugular access with
contrast injections to mark the superior aspect of the occlusion via a Multipurpose catheter. An adult
transseptal needle (Bard Electrophysiology Division C. R. Bard, Inc., Lowell, MA, USA) was used to create a
tract through a 6 French Raabe Sheath and traverse the occlusion. A 10-mm Snare (Cook, Bloomington,
IN, USA) cranially retracted the guidewire. Intravascular ultrasound was performed to further delineate
the diameter of the IVC at the lesion before dilation with a 6.0 mm  40 mm PTA balloon and a
10 mm  29 mm Palmaz Stent (Cordis Corporation, Bridgewater, NJ, USA) deployment. The patient lost
24.6 kg in 2 weeks with resolution of ascites and pedal edema.
<Learning objective: This case provides a unique approach to percutaneous intervention of inferior
vena cava chronic total occlusion in the setting of Budd–Chiari syndrome post-liver transplant. There
was use of an inferior and superior marker followed by use of transseptal needle to transverse the
occlusion followed by balloon dilation and stent placement. While the disease and intervention have
been described, the use of dual cranial/caudal markers and use of transseptal needle is unique to this
particular case.>
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Inferior vena cava (IVC) occlusion complicating liver transplan-
tation can cause severe morbidity in patients including portal
hypertension leading to abdominal fullness, weakness, abdominal
pain, lower extremity edema, hepatomegaly, splenomegaly, ascites,
distended abdominal vein, leg ulcers, and more rarely gastrointesti-
nal bleeding, jaundice, and hepatic encephalopathy [1].
Initial management of symptoms from IVC occlusion is medical
therapy with diuretics and anticoagulants. In some cases* Corresponding author at: Ochsner Medical Center, John Ochsner Heart and
Vascular Institute, 1514 Jefferson Highway, New Orleans, LA 70121, USA.
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IVC occlusion post-liver transplantation has been reported to be
infrequent at 1–6% (especially with piggyback anastomosis), but
can lead to portal hypertension, renal failure, pedal edema,
graft loss, and even death depending on the level of occlusion
[2–5]. Surgical porto-systemic shunt placement has been pro-
posed, and liver transplantation is also an option. Balloon dilation
of IVC occlusion is rarely successful because of rupture of new
anastomosis, acute re-occlusion, and restenosis. IVC stent place-
ment has been used for chronic occlusion in patients with Budd–
Chiari syndrome (BCS) whose symptoms were refractory to
conservative management [1–3,6–9]. Patients who underwent
IVC stent placement were shown to have improvement in venous
outﬂow [9]. IVC stenting with preceding catheter-directed
thrombolysis has shown to be beneﬁcial [9–11]. reserved.
Fig. 1.
Inferior vena cava occlusion below the hepatic transplant with multiple areas of non-occlusive thrombus is present on computed tomography venogram. Ascites
can be visualized as well. Additionally, there is heavy calciﬁcation present on the iliac arteries.
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A 64-year-old African American male 9 years post-orthotopic
liver transplantation who had IVC occlusion and BCS with chronic
pedal edema and ascites worsening over a 3-month period was
referred to interventional cardiology for evaluation and treatment.
The patient had hepatitis C with cirrhosis and underwent liver
transplant in 2003. He developed massive ascites, abdominal
distention, and lower extremity edema over the 3 months that he
could not ambulate and was restricted to his bed. He had gained
approximately 27 kg. An ultrasound of the liver showed patent
main portal vein with partially occlusive thrombus in the IVC and
renal veins bilaterally (as seen in Fig. 1), hepatomegaly, and a large
volume of ascites. Along with diuretics, he was put on antic-
oagulation as an outpatient. A venogram showed supra-hepatic
IVC occlusion and attempts to cross the occlusion were unsuccess-
ful by several operators. A vascular surgeon then saw him but no
surgical intervention was possible because the supra-hepatic
portion of his IVC had multiple collaterals to the superior vena cava
and right atrium (RA). He was then referred to interventional
cardiology.
On presentation, the patient weighed 128 kg. He had no jugular
venous distention. His abdomen was markedly distended with
ﬂuid wave, ascites, marked pitting edema involving his entire
lower extremity, back, and abdomen up to his chest wall. He also
had venous stasis dermatitis of his lower extremity. A computed
tomography venogram of his abdomen was performed as shown in
Fig. 1. The imaging showed ascites, right pleural effusion, and
supra-hepatic IVC stenosis 1 cm in diameter axially and 7 mm in
length. There were multiple areas of large clots in the infra-hepatic
IVC right around his anastamotic site with thrombus extending
into the left renal vein and at the bifurcation of the iliac veins. His
medications on presentation included losartan 50 mg daily,
felodipine 10 mg daily, furosemide 40 mg twice a day, insulin
formulations for his diabetes mellitus, tamsulosin for his benign
prostate hypertrophy, levothyroxine for hypothyroidism, and
pantoprazole for his gastroesophageal acid reﬂux.
Day 1: On 1/9/2013, the patient was brought to the catheteri-
zation laboratory and a 6 French sheath was inserted in right
common femoral vein. An IVC venogram showed complete
occlusion of the hepatic IVC at the liver transplant anastomosissite as well as partially thrombosed bilateral common iliac veins
and infra-renal IVC as shown in Fig. 2A. Left renal vein was sub-
totally occluded. A McNamara catheter was inserted into the left
renal vein and recombinant tissue plasminogen activator infusion
begun through the McNamara catheter at 1 mg/h and the sheath at
1 mg/h. The 6 French sheath was sutured in place and low-dose
heparin was also infused intravenously. The patient was trans-
ferred to the cardiac intensive care unit.
Day 2: Repeat venography showed no improvement on 1/10/
2013, with persistent supra-hepatic IVC occlusion around the
surgical anastomotic site, persistent thrombus in the infra-hepatic
IVC and left renal vein thrombosis. Multiple attempts to traverse the
IVC occlusion with numerous wires (such as .035 mm  180 mm
Stiff Angled Glidewire, .035 mm  190 mm followed by a
.035 mm  300 mm Supracore Wire, .014 mm  182 mm Choice
Xs Guidewire, 14 mm  190 mm BMW Guidewire) and catheters
failed (including 6 French IMA catheter, 4.1 French Multipurpose
catheter, 6 French DVX CUS Catheter, 6 French 125 cm MP Vista
Guide Catheter). A 6 French sheath was inserted into the right
internal jugular (IJ). A multipurpose catheter was inserted in the IJ
and positioned in the RA just above the IVC occlusion as shown in
Fig. 2B.
The femoral sheath was exchanged for an 8FR 55 cm Raabe
Sheath (Cook, Bloomington, IN, USA) followed by insertion of
8FR Mullins Sheath (Bard, Louisville, CO, USA). A transseptal
needle was introduced through the sheath and was used to
transverse the supra-hepatic IVC occlusion with ﬂuoroscopic
guidance of the target more proximally as marked by the
catheter from the IJ as shown in Fig. 3. The computed
tomography scan was used in addition to the catheter position
to conﬁrm where to direct the needle from the IVC to the RA
(Fig. 1). Once a tract was created, the guidewire was snared in
the RA with a 10-mm Snare (Cook). Intravascular ultrasound was
then performed to assess the diameter of the IVC prior to dilation
and stenting. A Mustang 6.0 mm  40 mm balloon (Boston
Scientiﬁc, Natick, MA, USA) was inﬂated at 10.0 atmosphere
followed by deployment of a 10 mm  29 mm Palmaz Stent on a
20 mm  4 cm balloon (BIB Balloon Cordis Corporation, Bridge-
water, NJ, USA) in the IVC occlusion (Fig. 4). Post-intervention,
the IVC was completely patent at the level of the lesion with
brisk ﬂow as shown in Fig. 5.
Fig. 3.
Inferior vena cava occlusion demonstrated cranially and caudally by dual injection from transjugular marking the superior border and transfemoral approach
marking the inferior border simultaneously (A). After traversing with a transseptal needle, a snare is used to externalize the guidewire (B).
Fig. 2.
Inferior vena cava occlusion demonstrated caudally (A) from a transfemoral approach with a multipurpose catheter and inferior vena cava occlusion
demonstrated cranially in (B) from a transjugular approach cranially with a multipurpose catheter.
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without complications. After the successful recanalization of the
supra-hepatic IVC, the patient was placed on aspirin and
clopidogrel for 1 month, and on an enoxaparin bridge until
therapeutic international normalized ratio was achieved with
warfarin. The patient started diuresing and lost nearly 18 kg duringthe index hospitalization with improvement in his mobility before
his discharge on 1/14/2013. In an outpatient visit 2 weeks post-
stenting, he weighed 103 kg with complete resolution of his ascites
and pedal edema. The patient remained asymptomatic 1-year
post-stenting. He reported that he was now able to ambulate
without any problems.
Fig. 4.
Aligning the a 29  10 Palmaz Stent on a 20 mm  4 cm balloon (BIB, Cordis, Miami Lakes, FL, USA) across the inferior vena cava occlusion in (A) followed by
inﬂation at 10.0 atmospheres in (B).
Fig. 5. Brisk ﬂow through the deployed stent in the inferior vena cava.
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IVC obstruction post-liver transplantation can lead to severe
morbidity in patients including portal hypertension (with
subsequent complications such as hepatomegaly, splenomegaly,
ascites, gastrointestinal bleeding, and hepatic encephalopathy)
and lower extremity edema. These symptoms can lead to severe
debilitation as in the case of this 64-year-old man who had failed
conventional medical therapy and an attempt to obtain IVC
patency. Successful recannalization of the supra-hepatic IVC
around his anastomotic site was achieved using a bi-directional
approach from the right IJ giving a superior target for tansseptal
needle to create a tract through which a guidewire from the
femoral vein could be snared cranially before dilation and stent
placement. While other case reports and trials have shown the
efﬁcacy and safety of IVC stent placement, this was a novel
approach with use of a transseptal needle which had excellent
results and no complications. Given the severe morbidity
associated with BCS, this technique can be used in patients that
fail conventional medical and interventional therapy. If a
transseptal needle is used, caution is warranted with recommen-
dation for superior target visualization.
IVC stenting had a technical success rate of 88–100% and a
clinical success rate of 86% in post-liver transplant patients
[1,2,9]. The patency rate is 96.7% with duplex ultrasonography for
IVC stents at mean follow-up of 58 months. Patients who were not
on anticoagulants post-procedure were more likely to have re-
occlusion with recurrence of symptoms. Therefore, anticoagula-
tion after IVC stenting for at least 6 months is highly recommended
for maintenance of patency [1].
Procedural complications associated with IVC stenting are rare
and include pericardial effusion, myocardial infarction during
balloon dilation of the stent, failure to cross the lesion with a wire,
renal failure, malpositioning, stent angulation, stent migration,
and mortality [1,4,7,10,11]. Up to 0.4% of the patients who undergo
stent placement for hepatic outﬂow abnormalities underwent
S. Karim et al. / Journal of Cardiology Cases 11 (2015) 73–77 77stent placement or re-transplantation due to liver function decline
[5]. It was reported that 13.6% of the patients who had undergone
percutaneous balloon angioplasty and stent placement needed to
undergo a second stent placement due to problems with
positioning, angulation, or migration of the ﬁrst stent [4].
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